IRIS
ZARBO, Ignazio Roberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 627
EU - Europa 327
AS - Asia 150
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 3
OC - Oceania 2
Totale 1.114
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 624
UA - Ucraina 118
CN - Cina 104
DE - Germania 61
IT - Italia 49
SE - Svezia 38
SG - Singapore 30
CZ - Repubblica Ceca 20
FI - Finlandia 16
FR - Francia 13
GB - Regno Unito 6
KR - Corea 4
CA - Canada 3
EU - Europa 3
IN - India 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
CL - Cile 1
EE - Estonia 1
ES - Italia 1
HK - Hong Kong 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
ME - Montenegro 1
PH - Filippine 1
PL - Polonia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.114
Salva come PNG Salva come JPEG
Città #
Chandler 192
Jacksonville 74
Princeton 56
Nanjing 25
Dearborn 22
Ann Arbor 20
Wilmington 19
Ashburn 18
Brno 17
Sassari 17
Singapore 17
Munich 16
Nanchang 14
New York 13
Beijing 12
Boardman 11
Mountain View 10
Hebei 9
Cagliari 8
Shenyang 8
Changsha 7
Jiaxing 7
Washington 7
Norwalk 5
Jinan 4
Milan 4
San Francisco 4
Seoul 4
Taizhou 4
Tianjin 4
Frankfurt am Main 3
Helsinki 3
Olomouc 3
Paris 3
San Mateo 3
Vélizy 3
Brussels 2
Kunming 2
Los Angeles 2
Monmouth Junction 2
Ningbo 2
Seattle 2
Andover 1
Augusta 1
Bologna 1
Buffalo 1
Canberra 1
Central 1
Cerreto Guidi 1
Clearwater 1
Edinburgh 1
Grafing 1
Guangzhou 1
Hangzhou 1
Hanover 1
Lappeenranta 1
London 1
Los Lunas 1
Markham 1
Mumbai 1
North Vancouver 1
Nuoro 1
Podgorica 1
Qingdao 1
Redwood City 1
Reston 1
San Juan 1
Selargius 1
Shanghai 1
Surabaya 1
Sydney 1
São Paulo 1
Taichung 1
Taiyuan 1
Tallinn 1
Tashkent 1
Tehran 1
Tokyo 1
Toronto 1
Trento 1
Woodbridge 1
Totale 697
Salva come PNG Salva come JPEG
Nome #
A rare case of lupus-like syndrome during treatment with interferon β-1a. 56
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis 53
An innovative training program based on virtual reality and treadmill: effects on gait of persons with multiple sclerosis 52
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 51
First evidence of the cross-training effect in multiple sclerosis 51
Virtual reality-treadmill training to improve gait in people with multiple sclerosis 50
Personality traits predict perceived health-related quality of life in persons with multiple sclerosis 49
Inflammation, infectious triggers, and Parkinson's disease 49
Proteomic analysis of CSF in multiple sclerosis patients and controls: a study in Sardinian population 49
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series. 44
MSRV as a prognostic factor in Sardinian patients: 10-year follow-up 40
Treadmill-virtual reality combined training program to improve gait in multiple sclerosis individuals 40
Paresi del IX e X nervi cranici da ematoma parietale post-traumatico della carotide interna in paziente con crisi convulsiva 39
Intensive treadmill training improves gait in moderately impaired multiple sclerosis individuals 38
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 38
A six-week intensive treadmill training improves walking ability in MS patients with moderate disability 36
Herv-k modulates the immune response in als patients 35
Sclerosi combinata del midollo, neuropatia ottica e deterioramento cognitivo post-resezione intestinale. Ruolo patogenetico della carenza di oligoelementi? 34
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 33
Long-term trajectory of acquired demyelinating syndrome and multiple sclerosis in children 29
Natalizumab as treatment option of refractory epilepsy in multiple sclerosis. 25
HERV-W/MSRV in the CSF significantly predicts the secondary progressive MS course upon 10-years follow-up 23
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients 23
Corpus callosum volumetrics and clinical progression in early multiple sclerosis 23
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study 22
Influence of psychological and social factors on self perceived health-related quality of life in patients with multiple sclerosis 19
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder 18
Antihuman Endogenous Retrovirus Immune Response and Adaptive Dysfunction in Autism 16
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 14
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 12
Signs and symptoms of COVID-19 in patients with multiple sclerosis 11
On a 5-year-old girl with multiple sclerosis treated with natalizumab 11
Rasagiline Withdrawal Syndrome in Parkinson’s Disease 9
Maternal multiple sclerosis is not a risk factor for neurodevelopmental disorders in offspring 8
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 8
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 7
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 7
RNA-binding proteins in autoimmunity: From genetics to molecular biology 6
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 6
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 6
Tdp‐43 and herv‐k envelope‐specific immunogenic epitopes are recognized in als patients 6
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 4
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 4
Multiple Sclerosis Progression and Relapse Activity in Children 3
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 3
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 2
Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study 2
Network analysis of gut microbial communities reveal key genera for a multiple sclerosis cohort with Mycobacterium avium subspecies paratuberculosis infection 1
Totale 1.165
Salva come PNG Salva come JPEG
Categoria #
all - tutte 7.853
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.853
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020204 54 2 11 0 20 21 42 4 23 4 22 1
2020/2021170 19 1 23 0 21 4 21 1 31 23 18 8
2021/2022153 12 0 3 1 2 2 3 23 12 27 12 56
2022/2023354 28 46 6 57 43 44 1 34 55 20 11 9
2023/2024169 16 16 8 6 36 18 1 11 0 7 15 35
2024/202539 39 0 0 0 0 0 0 0 0 0 0 0
Totale 1.165